The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Non-Invasive Prenatal Testing Devices Market Research Report 2025

Global Non-Invasive Prenatal Testing Devices Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1599726

No of Pages : 114

Ask Your Query
Synopsis
Noninvasive prenatal testing equipment, also known as noninvasive parenteral screening equipment, refers to the examination of the presence of fetal DNA in the mother's serum to detect the common fetal aneuploidy of the newborn genetic process.
The global Non-Invasive Prenatal Testing Devices market was valued at US$ 4884.4 million in 2023 and is anticipated to reach US$ 10060 million by 2030, witnessing a CAGR of 10.7% during the forecast period 2024-2030.
North American market for Non-Invasive Prenatal Testing Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-Invasive Prenatal Testing Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-Invasive Prenatal Testing Devices include Philips, Illumina, Thermo Fisher, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, QIAGEN, GE Healthcare and BGI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-Invasive Prenatal Testing Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Prenatal Testing Devices.
Report Scope
The Non-Invasive Prenatal Testing Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Invasive Prenatal Testing Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Invasive Prenatal Testing Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips
Illumina
Thermo Fisher
Beckman Coulter
Pacific Biosciences
Oxford Nanopore
QIAGEN
GE Healthcare
BGI
HYK Gene
Roche
Berry Genomics
CapitalBio
LabCorp
LifeLabs Genetics
LifeCodexx
Natera
Quest Diagnostics
Sequenom
Genpharm Services
Segment by Type
Ultrasound Devices
Next-Generation Sequencing Systems
Polymerase Chain Reaction Instruments
Microarrays
Other
Segment by Application
Hospital
Clinics
Research Laboratories
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Invasive Prenatal Testing Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Invasive Prenatal Testing Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Non-Invasive Prenatal Testing Devices Market Overview
1.1 Product Overview and Scope of Non-Invasive Prenatal Testing Devices
1.2 Non-Invasive Prenatal Testing Devices Segment by Type
1.2.1 Global Non-Invasive Prenatal Testing Devices Market Value Comparison by Type (2024-2030)
1.2.2 Ultrasound Devices
1.2.3 Next-Generation Sequencing Systems
1.2.4 Polymerase Chain Reaction Instruments
1.2.5 Microarrays
1.2.6 Other
1.3 Non-Invasive Prenatal Testing Devices Segment by Application
1.3.1 Global Non-Invasive Prenatal Testing Devices Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Research Laboratories
1.4 Global Non-Invasive Prenatal Testing Devices Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Prenatal Testing Devices Revenue 2019-2030
1.4.2 Global Non-Invasive Prenatal Testing Devices Sales 2019-2030
1.4.3 Global Non-Invasive Prenatal Testing Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-Invasive Prenatal Testing Devices Market Competition by Manufacturers
2.1 Global Non-Invasive Prenatal Testing Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-Invasive Prenatal Testing Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-Invasive Prenatal Testing Devices Average Price by Manufacturers (2019-2024)
2.4 Global Non-Invasive Prenatal Testing Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Invasive Prenatal Testing Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Invasive Prenatal Testing Devices, Product Type & Application
2.7 Non-Invasive Prenatal Testing Devices Market Competitive Situation and Trends
2.7.1 Non-Invasive Prenatal Testing Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Invasive Prenatal Testing Devices Players Market Share by Revenue
2.7.3 Global Non-Invasive Prenatal Testing Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Invasive Prenatal Testing Devices Retrospective Market Scenario by Region
3.1 Global Non-Invasive Prenatal Testing Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-Invasive Prenatal Testing Devices Global Non-Invasive Prenatal Testing Devices Sales by Region: 2019-2030
3.2.1 Global Non-Invasive Prenatal Testing Devices Sales by Region: 2019-2024
3.2.2 Global Non-Invasive Prenatal Testing Devices Sales by Region: 2025-2030
3.3 Global Non-Invasive Prenatal Testing Devices Global Non-Invasive Prenatal Testing Devices Revenue by Region: 2019-2030
3.3.1 Global Non-Invasive Prenatal Testing Devices Revenue by Region: 2019-2024
3.3.2 Global Non-Invasive Prenatal Testing Devices Revenue by Region: 2025-2030
3.4 North America Non-Invasive Prenatal Testing Devices Market Facts & Figures by Country
3.4.1 North America Non-Invasive Prenatal Testing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-Invasive Prenatal Testing Devices Sales by Country (2019-2030)
3.4.3 North America Non-Invasive Prenatal Testing Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-Invasive Prenatal Testing Devices Market Facts & Figures by Country
3.5.1 Europe Non-Invasive Prenatal Testing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-Invasive Prenatal Testing Devices Sales by Country (2019-2030)
3.5.3 Europe Non-Invasive Prenatal Testing Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Invasive Prenatal Testing Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Invasive Prenatal Testing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-Invasive Prenatal Testing Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-Invasive Prenatal Testing Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-Invasive Prenatal Testing Devices Market Facts & Figures by Country
3.7.1 Latin America Non-Invasive Prenatal Testing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-Invasive Prenatal Testing Devices Sales by Country (2019-2030)
3.7.3 Latin America Non-Invasive Prenatal Testing Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Invasive Prenatal Testing Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Invasive Prenatal Testing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-Invasive Prenatal Testing Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-Invasive Prenatal Testing Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-Invasive Prenatal Testing Devices Sales by Type (2019-2030)
4.1.1 Global Non-Invasive Prenatal Testing Devices Sales by Type (2019-2024)
4.1.2 Global Non-Invasive Prenatal Testing Devices Sales by Type (2025-2030)
4.1.3 Global Non-Invasive Prenatal Testing Devices Sales Market Share by Type (2019-2030)
4.2 Global Non-Invasive Prenatal Testing Devices Revenue by Type (2019-2030)
4.2.1 Global Non-Invasive Prenatal Testing Devices Revenue by Type (2019-2024)
4.2.2 Global Non-Invasive Prenatal Testing Devices Revenue by Type (2025-2030)
4.2.3 Global Non-Invasive Prenatal Testing Devices Revenue Market Share by Type (2019-2030)
4.3 Global Non-Invasive Prenatal Testing Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-Invasive Prenatal Testing Devices Sales by Application (2019-2030)
5.1.1 Global Non-Invasive Prenatal Testing Devices Sales by Application (2019-2024)
5.1.2 Global Non-Invasive Prenatal Testing Devices Sales by Application (2025-2030)
5.1.3 Global Non-Invasive Prenatal Testing Devices Sales Market Share by Application (2019-2030)
5.2 Global Non-Invasive Prenatal Testing Devices Revenue by Application (2019-2030)
5.2.1 Global Non-Invasive Prenatal Testing Devices Revenue by Application (2019-2024)
5.2.2 Global Non-Invasive Prenatal Testing Devices Revenue by Application (2025-2030)
5.2.3 Global Non-Invasive Prenatal Testing Devices Revenue Market Share by Application (2019-2030)
5.3 Global Non-Invasive Prenatal Testing Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Philips
6.1.1 Philips Corporation Information
6.1.2 Philips Description and Business Overview
6.1.3 Philips Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Philips Non-Invasive Prenatal Testing Devices Product Portfolio
6.1.5 Philips Recent Developments/Updates
6.2 Illumina
6.2.1 Illumina Corporation Information
6.2.2 Illumina Description and Business Overview
6.2.3 Illumina Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Illumina Non-Invasive Prenatal Testing Devices Product Portfolio
6.2.5 Illumina Recent Developments/Updates
6.3 Thermo Fisher
6.3.1 Thermo Fisher Corporation Information
6.3.2 Thermo Fisher Description and Business Overview
6.3.3 Thermo Fisher Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Thermo Fisher Non-Invasive Prenatal Testing Devices Product Portfolio
6.3.5 Thermo Fisher Recent Developments/Updates
6.4 Beckman Coulter
6.4.1 Beckman Coulter Corporation Information
6.4.2 Beckman Coulter Description and Business Overview
6.4.3 Beckman Coulter Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beckman Coulter Non-Invasive Prenatal Testing Devices Product Portfolio
6.4.5 Beckman Coulter Recent Developments/Updates
6.5 Pacific Biosciences
6.5.1 Pacific Biosciences Corporation Information
6.5.2 Pacific Biosciences Description and Business Overview
6.5.3 Pacific Biosciences Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pacific Biosciences Non-Invasive Prenatal Testing Devices Product Portfolio
6.5.5 Pacific Biosciences Recent Developments/Updates
6.6 Oxford Nanopore
6.6.1 Oxford Nanopore Corporation Information
6.6.2 Oxford Nanopore Description and Business Overview
6.6.3 Oxford Nanopore Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Oxford Nanopore Non-Invasive Prenatal Testing Devices Product Portfolio
6.6.5 Oxford Nanopore Recent Developments/Updates
6.7 QIAGEN
6.6.1 QIAGEN Corporation Information
6.6.2 QIAGEN Description and Business Overview
6.6.3 QIAGEN Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 QIAGEN Non-Invasive Prenatal Testing Devices Product Portfolio
6.7.5 QIAGEN Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GE Healthcare Non-Invasive Prenatal Testing Devices Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
6.9 BGI
6.9.1 BGI Corporation Information
6.9.2 BGI Description and Business Overview
6.9.3 BGI Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BGI Non-Invasive Prenatal Testing Devices Product Portfolio
6.9.5 BGI Recent Developments/Updates
6.10 HYK Gene
6.10.1 HYK Gene Corporation Information
6.10.2 HYK Gene Description and Business Overview
6.10.3 HYK Gene Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 HYK Gene Non-Invasive Prenatal Testing Devices Product Portfolio
6.10.5 HYK Gene Recent Developments/Updates
6.11 Roche
6.11.1 Roche Corporation Information
6.11.2 Roche Non-Invasive Prenatal Testing Devices Description and Business Overview
6.11.3 Roche Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Roche Non-Invasive Prenatal Testing Devices Product Portfolio
6.11.5 Roche Recent Developments/Updates
6.12 Berry Genomics
6.12.1 Berry Genomics Corporation Information
6.12.2 Berry Genomics Non-Invasive Prenatal Testing Devices Description and Business Overview
6.12.3 Berry Genomics Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Berry Genomics Non-Invasive Prenatal Testing Devices Product Portfolio
6.12.5 Berry Genomics Recent Developments/Updates
6.13 CapitalBio
6.13.1 CapitalBio Corporation Information
6.13.2 CapitalBio Non-Invasive Prenatal Testing Devices Description and Business Overview
6.13.3 CapitalBio Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CapitalBio Non-Invasive Prenatal Testing Devices Product Portfolio
6.13.5 CapitalBio Recent Developments/Updates
6.14 LabCorp
6.14.1 LabCorp Corporation Information
6.14.2 LabCorp Non-Invasive Prenatal Testing Devices Description and Business Overview
6.14.3 LabCorp Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 LabCorp Non-Invasive Prenatal Testing Devices Product Portfolio
6.14.5 LabCorp Recent Developments/Updates
6.15 LifeLabs Genetics
6.15.1 LifeLabs Genetics Corporation Information
6.15.2 LifeLabs Genetics Non-Invasive Prenatal Testing Devices Description and Business Overview
6.15.3 LifeLabs Genetics Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 LifeLabs Genetics Non-Invasive Prenatal Testing Devices Product Portfolio
6.15.5 LifeLabs Genetics Recent Developments/Updates
6.16 LifeCodexx
6.16.1 LifeCodexx Corporation Information
6.16.2 LifeCodexx Non-Invasive Prenatal Testing Devices Description and Business Overview
6.16.3 LifeCodexx Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 LifeCodexx Non-Invasive Prenatal Testing Devices Product Portfolio
6.16.5 LifeCodexx Recent Developments/Updates
6.17 Natera
6.17.1 Natera Corporation Information
6.17.2 Natera Non-Invasive Prenatal Testing Devices Description and Business Overview
6.17.3 Natera Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Natera Non-Invasive Prenatal Testing Devices Product Portfolio
6.17.5 Natera Recent Developments/Updates
6.18 Quest Diagnostics
6.18.1 Quest Diagnostics Corporation Information
6.18.2 Quest Diagnostics Non-Invasive Prenatal Testing Devices Description and Business Overview
6.18.3 Quest Diagnostics Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Quest Diagnostics Non-Invasive Prenatal Testing Devices Product Portfolio
6.18.5 Quest Diagnostics Recent Developments/Updates
6.19 Sequenom
6.19.1 Sequenom Corporation Information
6.19.2 Sequenom Non-Invasive Prenatal Testing Devices Description and Business Overview
6.19.3 Sequenom Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Sequenom Non-Invasive Prenatal Testing Devices Product Portfolio
6.19.5 Sequenom Recent Developments/Updates
6.20 Genpharm Services
6.20.1 Genpharm Services Corporation Information
6.20.2 Genpharm Services Non-Invasive Prenatal Testing Devices Description and Business Overview
6.20.3 Genpharm Services Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Genpharm Services Non-Invasive Prenatal Testing Devices Product Portfolio
6.20.5 Genpharm Services Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Invasive Prenatal Testing Devices Industry Chain Analysis
7.2 Non-Invasive Prenatal Testing Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Invasive Prenatal Testing Devices Production Mode & Process
7.4 Non-Invasive Prenatal Testing Devices Sales and Marketing
7.4.1 Non-Invasive Prenatal Testing Devices Sales Channels
7.4.2 Non-Invasive Prenatal Testing Devices Distributors
7.5 Non-Invasive Prenatal Testing Devices Customers
8 Non-Invasive Prenatal Testing Devices Market Dynamics
8.1 Non-Invasive Prenatal Testing Devices Industry Trends
8.2 Non-Invasive Prenatal Testing Devices Market Drivers
8.3 Non-Invasive Prenatal Testing Devices Market Challenges
8.4 Non-Invasive Prenatal Testing Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock